Qiagen NV
NYSE:QGEN 3:59:58 PM EDT
| Market Cap (Intraday) | 10.85B |
| Current PE | 24.18 |
| Forward PE | 19.01 |
| 2yr Forward PE | 20.68 |
| 10-Day MA | $47.35 |
| 50-Day MA | $48.55 |
| 200-Day MA | $50.32 |
Qiagen NV Stock, NYSE:QGEN
Hulsterweg 82, Venlo, Limburg 5912 PL
Netherlands
Phone: +31.77.355.66.00
Number of Employees: 5610
Description
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.